Catheter having a cutting balloon including multiple cavities or multiple channels

Information

  • Patent Grant
  • 7887557
  • Patent Number
    7,887,557
  • Date Filed
    Thursday, August 14, 2003
    21 years ago
  • Date Issued
    Tuesday, February 15, 2011
    13 years ago
Abstract
An angioplasty balloon catheter and method of making and using the same. The balloon catheter may include a catheter shaft and a balloon coupled to the shaft. The balloon may include one or more cutting edges or member and may include a plurality of chambers defined therein.
Description
FIELD OF THE INVENTION

The present invention pertains to angioplasty and angioplasty balloon catheters. More particularly, the present invention pertains to angioplasty balloon catheters that include one or more cutting edges coupled to the angioplasty balloon.


BACKGROUND OF THE INVENTION

Heart and vascular disease are major problems in the United States and throughout the world. Conditions such as atherosclerosis result in blood vessels becoming blocked or narrowed. This blockage can result in lack of oxygenation of the heart, which has significant consequences since the heart muscle must be well oxygenated in order to maintain its blood pumping action.


Occluded, stenotic, or narrowed blood vessels may be treated with a number of relatively non-invasive medical procedures including percutaneous transluminal angioplasty (PTA), percutaneous transluminal coronary angioplasty (PTCA), and atherectomy. Angioplasty techniques typically involve the use of a balloon catheter. The balloon catheter is advanced over a guidewire so that the balloon is positioned adjacent a stenotic lesion. The balloon is then inflated and the restriction of the vessel is opened.


One of the major obstacles in treating coronary artery disease and/or treating blocked blood vessels is re-stenosis. Evidence has shown that cutting the stenosis, for example, with an angioplasty balloon equipped with a cutting blade, during treatment can reduce incidence of re-stenosis. Additionally, cutting the stenosis may reduce trauma at the treatment site and/or may reduce the trauma to adjacent healthy tissue. Cutting blades may also be beneficial additions to angioplasty procedures when the targeted occlusion is hardened or calcified. It is believed typical angioplasty balloons, alone, may not be able to expand certain of these hardened lesions. Thus, angioplasty balloons equipped with cutting edges have been developed to attempt to enhance angioplasty treatments. There is an ongoing need for improved angioplasty devices, including cutting angioplasty balloons, and improved methods of treating intravascular stenoses and occlusions.


Another potential obstacle that may accompany treatments that include expansion of a stenosis with an angioplasty balloon is the removal of the balloon from the vessel. This is because when the balloon is deflated, it may tend to maintain a relatively large profile. Moreover, if the balloon includes a cutting edge, the potential exists for the cutting edge to be disposed at a large profile region of the balloon. This could subject healthy tissue to unnecessary contact with the cutting edge and resultant abrasion or cutting during the balloon removal procedure. Accordingly, there is an ongoing need for improved angioplasty devices, including cutting angioplasty balloons, with improved re-folding abilities.


SUMMARY OF THE INVENTION

The present invention relates to angioplasty balloon catheters. In at least some embodiments, an exemplary balloon catheter may include a catheter shaft having a balloon coupled thereto. The balloon may include one or more cutting members or blades. Additionally, the balloon may include a number of channels or chambers extending therethrough that may, for example, improve the folding and refolding abilities of the balloon and decrease balloon elongation. These and other features are described in more detail below.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a partial cross-sectional schematic side view of an exemplary medical device disposed in a blood vessel;



FIG. 2 is a partially cut-away perspective view of an example medical device;



FIG. 3 is a longitudinal cross-sectional view of the device shown in FIG. 2;



FIG. 4 is a cross-sectional view taken through line 4-4 in FIGS. 2 and 3;



FIG. 5 is a cross-sectional view of the device illustrated in FIG. 4, wherein the balloon is deflated;



FIG. 6 is a cross-sectional view of another example medical device;



FIG. 7 is a cross-sectional view of another example medical device;



FIG. 8 is a cross-sectional view of another example medical device;



FIG. 9 is a cross-sectional view of another example medical device;



FIG. 10 is a cross-sectional view of an extruded balloon tube used to form a multi-chamber balloon; and



FIG. 11 is a cross-sectional view of an alternative balloon tube used to form a multi-chamber balloon medical device.





DETAILED DESCRIPTION OF THE INVENTION

The following description should be read with reference to the drawings wherein like reference numerals indicate like elements throughout the several views. The detailed description and drawings illustrate example embodiments of the claimed invention.


Angioplasty techniques that include the use of an angioplasty balloon with cutting blades attached thereto have been shown to be a desirable treatment modality for at least some intravascular interventions. FIG. 1 illustrates a distal portion of an exemplary angioplasty catheter 10 positioned in a blood vessel 12 adjacent an intravascular lesion or stenosis 14. Catheter 10 may include a balloon 16 coupled to a catheter shaft 18. Balloon 16 may include one or more cutting members 20 that can be used to cut or sever lesion 14. In general, catheter 10 may be advanced over a guidewire 22 through the vasculature to a target area. Balloon 16 can then be inflated to expand lesion 14 and cutting members 20 can cut lesion 14. The target area may be within any suitable peripheral or cardiac location.


A partially cut-away perspective view of a portion of catheter 10 is shown in FIG. 2. Here it can be seen that balloon 16 may include a plurality of channels or cavities 24 formed therein. The number, shape, and arrangement of cavities 24 may vary. For example, balloon 16 may include two, three, four, five, six, or more channels 24 that extend through all of or a portion of balloon 16. Channels 24 may be distributed regularly, irregularly, randomly, or in any suitable manner through balloon. Additionally, channels 24 may extend along essentially the entire length of balloon 16 or channels 24 may extend along only a portion of the balloon length.


In at least some embodiments, cavities 24 may be defined by a plurality of dividing sections 26 projecting radially inward from the interior wall of balloon 16. Sections 26 may be attached to, be integral with, or otherwise be coupled to balloon 16 and may extend between the interior wall of the balloon 16 and a central balloon tubular portion 31 which forms a lumen 32 adjacent the shaft 18. In some embodiments, shaft 18 may include an inner tubular member 28 and an outer tubular member 30 (more clearly seen in FIG. 3), and sections 26 may attach to an inner tubular member 28. In other embodiments, sections 26 may attach to an inner sleeve or tube-shaped member generally disposed over shaft 18 and/or inner tubular member 28. This tubular portion 31 which forms a lumen 32 can, in a prefered embodiment, be an integrally formed portion of the balloon 16.


Balloon 16 may be made from typical angioplasty balloon materials including polymers such as polyethylene terephthalate (PET), polyetherimid (PEI), polyethylene (PE), etc. Some other examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM), polybutylene terephthalate (PBT), polyether block ester, polyurethane, polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, a polyether-ester elastomer such as ARNITEL® available from DSM Engineering Plastics), polyester (for example, a polyester elastomer such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example, available under the trade name PEBAX®), silicones, Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example, REXELL®), polyetheretherketone (PEEK), polyimide (PI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), polysulfone, nylon, perfluoro(propyl vinyl ether) (PFA), other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like.


In some embodiments, it may be desirable to use high modulus or generally stiffer materials so as to reduce balloon elongation. The above list of materials includes some examples of higher modulus materials. Some other examples of stiffer materials include polymers blended with liquid crystal polymer (LCP) as well as the materials listed above. For example, the mixture can contain up to about 5% LCP. Additionally, due to the relative inelasticity of cutting members 20, balloon elongation could create shear forces between cutting members 20 and balloon 16. Thus, reducing balloon elongation may also help maintain the integrity of the coupling between balloon 16 and cutting members 20. By including channels 24 in balloon 16, it has been found possible to more precisely control the inflation, folding and refolding of balloon 16. For example, channels 24 can allow balloon 16 to be inflated more evenly, which may reduce balloon elongation. Because balloon elongation can be reduced by including channels 24, it is possible to manufacture balloon 16 from lower modulus materials, which may be easier to refold than stiffer materials.


Another cross-sectional view of catheter 10 is shown in FIG. 3. Here, inner tubular member 28 and outer tubular member 30 of shaft 18 can be more clearly seen. Tubular members 28/30 may be manufactured from a number of different materials. For example, tubular members 28/30 may be made of metals, metal alloys, polymers, metal-polymer composites or any other suitable materials. Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316L stainless steel; nickel-titanium alloy such as linear-elastic or super-elastic Nitinol, nickel-chromium alloy, nickel-chromium-iron alloy, cobalt alloy, tungsten or tungsten alloys, MP35-N (having a composition of about 35% Ni, 35% Co, 20% Cr, 9.75% Mo, a maximum 1% Fe, a maximum 1% Ti, a maximum 0.25% C, a maximum 0.15% Mn, and a maximum 0.15% Si), hastelloy, monel 400, inconel 825, or the like; or other suitable material. Some examples of suitable polymers include those described above in relation to balloon 16.


Tubular members 28/30 may be arranged in any appropriate way. For example, in some embodiments inner tubular member 28 can be disposed coaxially within outer tubular member 30. According to these embodiments, inner and outer tubular members 28/30 may or may not be secured to one another along the general longitudinal axis of catheter shaft 18. Alternatively, inner tubular member 28 may follow the inner wall or otherwise be disposed adjacent the inner wall of outer tubular member 30. Again, inner and outer tubular members 28/30 may or may not be secured to one another. For example, inner and outer tubular members 28/30 may be bonded, welded (including tack welding or any other welding technique), or otherwise secured at a bond point. In some embodiments, the bond point may be generally disposed near the distal end of catheter shaft 18. However, one or more bond points may be disposed at any position along shaft 18. The bond may desirably impact, for example, the stability and the ability of tubular members 28/30 to maintain their position relative to one another. In still other embodiments, inner and outer tubular member 28/30 may be adjacent to and substantially parallel to one another so that they are non-overlapping. In these embodiments, shaft 18 may include an outer sheath that is disposed over tubular members 28/30.


Inner tubular member 28 may include an inner lumen 32. In at least some embodiments, inner lumen 32 is a guidewire lumen. Accordingly, catheter 10 can be advanced over a guidewire to the desired location. The guidewire lumen may extend along essentially the entire length of catheter shaft 18 so that catheter 10 resembles traditional “over-the-wire” catheters. Alternatively, the guidewire lumen may extend along only a portion of shaft 18 so that catheter 10 resembles “single-operator-exchange” or “rapid-exchange” catheters.


In some embodiments, one or more marker members 33 may be coupled to catheter 10. Marker members 33 may include, be made from, be doped with, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids the user of catheter 10 in determining its location. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, plastic material loaded with a radiopaque filler, and the like.


Shaft 18 may also include an inflation lumen 34 that is in fluid communication with chambers 24 and may be used, for example, to transport inflation media to and from chambers 24 and/or balloon 16. The location and position of inflation lumen 34 may vary, depending on the configuration of tubular members 28/30. For example, when outer tubular member 30 is disposed over inner tubular member 28, inflation lumen 34 may be defined within the space between tubular members 28/30. Moreover, depending on the position of inner tubular member 28 within outer tubular member 30, the shape of lumen 34 (i.e., the shape adjacent shaft 18) may vary. For example, if inner tubular member 28 is attached to or disposed adjacent to the inside surface of outer tubular member 30, then inflation lumen 34 may be generally half-moon in shape; whereas if inner tubular member 28 is generally coaxial with outer tubular member 30, then inflation lumen 34 may be generally ring-shaped or annular in shape. It can be appreciated that if outer tubular member 30 is disposed alongside inner tubular member 28, then lumen 34 may be the lumen of outer tubular member 30 or it may be the space defined between the outer surface of tubular members 28/30 and the outer sheath disposed thereover.


Balloon 16 may be coupled to catheter shaft 18 in any of a number of suitable ways. For example, balloon 16 may be adhesively or thermally bonded to shaft 18. In some embodiments, a proximal portion 36 of balloon 16 may be bonded to shaft 18, for example, at outer tubular member 30, and a distal portion 38 may be bonded to shaft 18, for example, at inner tubular member 28. The exact bonding positions, however, may vary. It can be appreciated that a section of proximal portion 36 may not have sections 26 extending therefrom in order for suitable bonding between balloon 16 and outer tubular member 30. A folding spring (not shown) may be coupled to balloon 16, for example, adjacent proximal portion 36, which may further help in balloon folding and refolding. A description of a suitable folding spring can be found in U.S. Pat. No. 6,425,882, which is incorporated herein by reference. A2/////


Another cross-sectional view of balloon 16 is shown in FIG. 4. Similar to what is shown in the other figures, it can be seen that balloon 16 may include four chambers 24 and four dividing sections 26. Of course, the number and arrangement of chambers 24 and sections 26 may vary, as stated above. It can also be seen here that sections 26 may have dividing walls that project inwardly and connect to a tubular inner sleeve portion 44 of balloon 16 that may be, for example, configured to attach to shaft 18 and/or inner tubular member 28. Alternatively, balloon 16 may not include inner sleeve portion 44 and, instead, projections may attach directly to tubular member 28. inner Sleeve portion 44 may be made from the same materials as balloon 16 and can be integrally formed or it may be made from different materials.



FIG. 5 illustrates balloon 16 in a deflated configuration. Venting inflation media from balloon 16 allows balloon 16 to re-fold inwardly into a collapsed, deflated configuration. In addition or as an alternative to this feature, a vacuum can be applied to chambers 24 (e.g., by applying a vacuum to lumen 34) in order to facilitate their collapse. This may allow balloon 16 to re-fold to a consistent and predictable configuration where, for example, cutting members 20 are moved radially inward and one or more “wings” or flaps are defined in balloon 16. By forming wings, balloon 16 may have a lower profile so that balloon 16 may be easily removed from the vasculature. Additionally, it may be possible for the wings to fold over cutting members 20 so as to guard healthy vascular tissue from unplanned contact with cutting members 20.


A cross-sectional view of another example balloon 116, suitable for use with catheter 10 and other medical devices, is shown in FIG. 6. Balloon 116 is similar to balloon 16, except that balloon 116 may include a plurality of stiffened regions 146. Stiffened regions 146 may generally be sections of balloon 116 that are configured to provide additional structural support, for example, adjacent cutting members 20. This additional structural support may be desirable by facilitating the coupling of cutting members 20 to balloon 16 and by providing support so that cutting members 20 remain secured to balloon 16 during placement and use of balloon 16. In some embodiments, stiffened regions 146 may be defined by blending or adding LCP or any other suitably stiff material (including polymers and metals) with balloon 16. Any suitable means of stiffening may be included without departing from the spirit of the invention.



FIGS. 7 and 8 illustrate additional example balloons 216/316 that have varying numbers of chambers 224/324 and sections 226/326. For example, FIG. 7 illustrates balloon 216 having three chambers 224 and three sections 226. FIG. 8 illustrates balloon 216 having six chambers 324 and six sections 326. These example illustrations are meant to show that essentially any number of chambers 224/324 and sections 226/326 may be included in any of the various embodiments of balloons described herein.


Another example balloon 416 is shown in FIG. 9. Balloon 416 is similar to other balloons described herein, except that chambers 424 and dividing sections 426 are defined within the wall of balloon 416. According to this embodiment, balloon 416 may be somewhat thicker than typical angioplasty balloons so that chambers 424 can be formed therein. The additional thickness may be desirable for a number of reasons. For example, thickened balloon 416 may have improved longitudinal stability and, thus, be less likely to elongate.



FIG. 10 is a cross-sectional view of an extruded tubular member that can be used to form a balloon of the present invention. Balloon tube 516 is similar to other balloons described herein and may include lumens 524 formed in the balloon wall. As it can be seen, lumens 524 may be round in shape and can be dispersed regularly throughout the balloon wall. However, chambers 524 can have essentially any appropriate shape, can vary in number, and can be dispersed in any pattern in the balloon wall. FIG. 11 shows one such alternative embodiment of a balloon tube 616 with wall lumens 624 formed during extrusion that are oval or pill-shaped.


The balloon tubes 516 or 616 are used to form balloons of preferred embodiments of the present invention. The balloon tube is placed within a mold chamber that has a preferred exterior shape for the balloon. The balloon tube is heated and expanded utilizing a gas or liquid such that the expanded chambers are formed from the lumens 524 or 624. The wall thicknesses of the balloon material surrounding the lumens are selected such that thinning occurs during expansion in the mold, but not to a degree that compromises burst pressure of the final balloon product. The various balloon tube lumens may be inflated individually or simultaneously to form final chambers of desired dimension in the overall balloon cross section.


As stated above, including a plurality of chambers in the balloon with dividing sections extending radially between chambers may help to reduce balloon elongation. Additionally, the chambers and walls between the chambers may also be desirable by facilitating re-folding. For example, the chambers can be vented by pulling vacuum or other means so as to partially collapse the balloon which will preferentially fold first at the thinner areas between dividing sections. At these creases, the balloon can more easily and consistently re-fold when the entire balloon is deflated. By placing the cutting blades to extend longitudinally at a circumferential position between the wall dividing sections or chambers, the cutting blades will be preferentially drawn radially inward away from the vessel wall during deflation. In some preferred embodiments, the blades are positioned at about the circumferential mid-point between adjacent walls forming a chamber as depicted in FIGS. 4 and 5.


It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.

Claims
  • 1. A medical device, comprising: an elongate shaft;an expandable balloon coupled to the shaft, the balloon including an inside surface;wherein the shaft includes an outer tubular member, an inner tubular member, and a single common inflation lumen disposed therebetween;a plurality of dividing sections extending radially inward from the inside surface of the balloon to define a plurality of chambers in the balloon, each of the chambers extending along essentially the entire length of the balloon;one or more cutting members coupled to the balloon; andwherein the single common inflation lumen is in fluid communication with all of the chambers of the balloon.
  • 2. The device of claim 1, wherein the inner tubular member includes an inner lumen extending at least partially therethrough.
  • 3. An angioplasty balloon catheter, comprising: a catheter shaft, the shaft including an inner tubular member having an inner lumen extending therethrough, an outer tubular member, and a single common inflation lumen disposed between the inner and outer tubular members;an expandable balloon coupled to the shaft, the balloon including a balloon wall and a plurality of inner chambers each extending along essentially the entire length of the balloon;wherein the inflation lumen is in fluid communication with all of the inner chambers; andat least one cutting member coupled to the outer wall of the balloon.
  • 4. The catheter of claim 3, wherein the balloon includes three inner chambers.
  • 5. The catheter of claim 3, wherein the balloon includes four inner chambers.
  • 6. An angioplasty balloon catheter, comprising: a catheter shaft;a multi-chamber balloon coupled to the shaft, each of the chambers extending along essentially the entire length of the balloon, the balloon including an inner sleeve, an outer wall, and a plurality of internal wall segments extending between the inner sleeve and the outer wall;wherein the shaft includes a single common inflation lumen that supplies inflation media to each chamber of the multi-chamber balloon; andone or more longitudinally extending cutting members coupled to the outer wall of the balloon at circumferential locations between adjacent internal wall segments.
  • 7. The catheter of claim 6, wherein the balloon includes three internal wall segments and three chambers defined between adjacent pairs of internal wall segments.
  • 8. The catheter of claim 6, wherein the balloon includes four internal wall segments and four chambers defined between adjacent pairs of internal wall segments.
  • 9. A method of using a cutting balloon catheter, comprising the steps of: providing a cutting balloon catheter, the catheter including a catheter shaft and a multi-chamber cutting balloon coupled to the shaft, the multi-chamber balloon including an inner sleeve, an outer wall, a plurality of internal wall segments extending between the inner sleeve and the outer wall, a plurality of chambers defined between pairs of internal wall segments, each chamber extending along essentially the entire length of the balloon, and one or more cutting members coupled to the outer surface of the balloon between adjacent internal wall segments;advancing the cutting balloon catheter through a blood vessel to a position adjacent an area of interest;inflating the balloon by infusing inflation media into the chambers, wherein inflating the balloon includes inflating each chamber of the multi-chamber cutting balloon through a single common inflation lumen;deflating the balloon by venting the inflation media from the chambers to preferentially draw the cutting members radially inward; andwithdrawing the cutting balloon catheter from the blood vessel.
  • 10. The method of claim 9, wherein the step of deflating the balloon by venting the inflation media from the chambers includes applying a vacuum to the chambers.
US Referenced Citations (140)
Number Name Date Kind
2816552 Hoffman Dec 1957 A
3174851 Buehler et al. Mar 1965 A
3351463 Rozner et al. Nov 1967 A
3635223 Klieman Jan 1972 A
3749085 Willson et al. Jul 1973 A
3753700 Harrison et al. Aug 1973 A
3990453 Douvas et al. Nov 1976 A
4140126 Choudhury Feb 1979 A
4141364 Schultze Feb 1979 A
4263236 Briggs et al. Apr 1981 A
4273128 Lary Jun 1981 A
4292974 Fogarty et al. Oct 1981 A
4406656 Hattler et al. Sep 1983 A
4465072 Taheri Aug 1984 A
4490421 Levy Dec 1984 A
4572186 Gould et al. Feb 1986 A
4574781 Chin Mar 1986 A
4608984 Fogarty Sep 1986 A
4627436 Leckrone Dec 1986 A
4685458 Leckrone Aug 1987 A
4686982 Nash Aug 1987 A
4696667 Masch Sep 1987 A
4705517 DiPisa, Jr. Nov 1987 A
4723549 Wholey et al. Feb 1988 A
4728319 Masch Mar 1988 A
4747405 Leckrone May 1988 A
4748982 Horzewski et al. Jun 1988 A
4784636 Rydell Nov 1988 A
4787388 Hofmann Nov 1988 A
4790813 Kensey Dec 1988 A
4793348 Palmaz Dec 1988 A
4796629 Grayzel Jan 1989 A
4799479 Spears Jan 1989 A
RE32983 Levy Jul 1989 E
4886061 Fischell et al. Dec 1989 A
4921483 Wijay et al. May 1990 A
4921484 Hillstead May 1990 A
4936845 Stevens Jun 1990 A
4966604 Reiss Oct 1990 A
RE33561 Levy Mar 1991 E
5009659 Hamlin et al. Apr 1991 A
5030201 Palestrant Jul 1991 A
5042985 Elliott et al. Aug 1991 A
5047040 Simpson et al. Sep 1991 A
5049132 Shaffer et al. Sep 1991 A
5078722 Stevens Jan 1992 A
5078725 Enderle et al. Jan 1992 A
5085662 Willard Feb 1992 A
5087265 Summers Feb 1992 A
5100424 Jang et al. Mar 1992 A
5100425 Fischell et al. Mar 1992 A
5102390 Crittenden et al. Apr 1992 A
5116318 Hillstead May 1992 A
5135482 Neracher Aug 1992 A
5152773 Redha Oct 1992 A
5156594 Keith Oct 1992 A
5156610 Reger Oct 1992 A
5158564 Schnepp-Pesch et al. Oct 1992 A
5176693 Pannek, Jr. Jan 1993 A
5180368 Garrison Jan 1993 A
5196024 Barath Mar 1993 A
5197965 Cherry et al. Mar 1993 A
5209749 Buelna May 1993 A
5209799 Vigil May 1993 A
5226430 Spears et al. Jul 1993 A
5226887 Farr et al. Jul 1993 A
5248311 Black et al. Sep 1993 A
5250059 Andreas et al. Oct 1993 A
5254089 Wang Oct 1993 A
5300025 Wantink Apr 1994 A
5308323 Sogawa et al. May 1994 A
5318576 Plassche, Jr. et al. Jun 1994 A
5320634 Vigil et al. Jun 1994 A
5328472 Steinke et al. Jul 1994 A
5336234 Vigil et al. Aug 1994 A
5372601 Lary Dec 1994 A
5395361 Fox et al. Mar 1995 A
5411466 Hess May 1995 A
5415654 Daikuzono May 1995 A
5417653 Sahota et al. May 1995 A
5417703 Brown et al. May 1995 A
5425711 Ressemann et al. Jun 1995 A
5437659 Leckrone Aug 1995 A
5441510 Simpson et al. Aug 1995 A
5456681 Hajjar Oct 1995 A
5470415 Perkins et al. Nov 1995 A
5496308 Brown et al. Mar 1996 A
5507760 Wynne et al. Apr 1996 A
5507761 Duer Apr 1996 A
5522818 Keith et al. Jun 1996 A
5522825 Kropf et al. Jun 1996 A
5549556 Ndondo-Lay et al. Aug 1996 A
5569195 Saab Oct 1996 A
5569277 Evans et al. Oct 1996 A
5571087 Ressemann et al. Nov 1996 A
5616149 Barath Apr 1997 A
5628761 Rizik May 1997 A
5643296 Hundertmark et al. Jul 1997 A
5645529 Fagan et al. Jul 1997 A
5681336 Clement et al. Oct 1997 A
5713913 Lary et al. Feb 1998 A
5718684 Gupta Feb 1998 A
5720724 Ressemann et al. Feb 1998 A
5792105 Lin et al. Aug 1998 A
5797935 Barath Aug 1998 A
5814016 Valley et al. Sep 1998 A
5827201 Samson et al. Oct 1998 A
5860954 Ropiak Jan 1999 A
5895402 Hundertmark et al. Apr 1999 A
5931819 Fariabi Aug 1999 A
6024722 Rau et al. Feb 2000 A
6039699 Viera Mar 2000 A
6066149 Samson et al. May 2000 A
6068623 Zadno-Azizi et al. May 2000 A
6139510 Palermo Oct 2000 A
6142975 Jalisi et al. Nov 2000 A
6165140 Ferrera Dec 2000 A
6165167 Delaloye Dec 2000 A
6165292 Abrams et al. Dec 2000 A
6168571 Solar et al. Jan 2001 B1
6190332 Muni et al. Feb 2001 B1
6193686 Estrada et al. Feb 2001 B1
6217549 Selmon et al. Apr 2001 B1
6217567 Zadno-Azizi et al. Apr 2001 B1
6241690 Burkett et al. Jun 2001 B1
6254550 McNamara et al. Jul 2001 B1
6306105 Rooney et al. Oct 2001 B1
6344029 Estrada et al. Feb 2002 B1
6355016 Bagaoisan et al. Mar 2002 B1
6379362 Birk et al. Apr 2002 B1
6383146 Klint May 2002 B1
6387075 Stivland et al. May 2002 B1
6398798 Selmon et al. Jun 2002 B2
6409863 Williams et al. Jun 2002 B1
6425882 Vigil Jul 2002 B1
6458076 Pruitt Oct 2002 B1
6471673 Kasterhofer Oct 2002 B1
6533754 Hisamatsu et al. Mar 2003 B1
6544276 Azizi Apr 2003 B1
7008438 O'Brien Mar 2006 B2
Foreign Referenced Citations (8)
Number Date Country
34 00 416 Jul 1985 DE
3402573 Aug 1985 DE
35 19 626 Dec 1986 DE
0 291 170 Nov 1988 EP
0 414 350 Feb 1991 EP
1 547 328 Jun 1979 GB
WO 9007909 Jul 1990 WO
WO 9117714 Nov 1991 WO
Related Publications (1)
Number Date Country
20050038383 A1 Feb 2005 US